|
Ayush ministry forms Ayush R&D taskforce for Covid-19 treatment
|
|
Our Bureau, Mumbai
March 25 , 2021
|
|
|
The Union Ministry of Ayush has formed an inter-disciplinary Ayush Research & Development (R&D) taskforce for Covid-19 treatment.
The inter disciplinary Ayush Research and Development taskforce has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in Covid-19 positive cases through a thorough review and consultative process of experts of high repute from different organizations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (Ayush-64).
The Ayush R&D taskforce was chaired by Prof. Bhushan Patwardhan and having representation from scientists including Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR), All India Institute of Medical Science (AIIMS) and Ayush Institutions.
The taskforce has taken up the proposals received from screening committees of councils and proactively explored possibilities based on available leads, said Ayush minister, Kiren Rijiju (additional charge).
Union Ministry of Ayush has constituted core group of experts under the chairmanship of Prof. Bhushan Patwardhan to identify and propose formulations on Covid-19 which are in line with Classical Ayurveda principles and have substantial leads on Covid-19 viz. one for prophylaxis as immunomodulatory, another for management of Covid-19 with antiviral properties and one product for post Covid-19 care, he further stated.
Ayush has launched inter disciplinary studies involving Ayush interventions for Covid-19 based on recommendations of taskforce. Under various research organizations and National Institutes under Union Ministry of Ayush, 120 research studies at 141 centres in the country are being conducted on Ayush interventions as prophylactic interventions.
The Covid-19 related studies are 42 prophylactic studies, 38 interventional studies, 09 observational studies, 22 Pre-clinical/experimental studies (including 13 Ayush-DBT studies), 09 other studies (survey studies; monographs preparation), 141study sites –(including pre-clinical study centres) and 79 studies completed.
All India Institute of Ayurveda (AIIA), New Delhi is identified as the Dedicated Covid Health Center where till 435 patients were treated and 411 patients completed the treatment. Intervention was as per the Ayush guidelines for management of Covid-19 mild to moderate cases. The study reflected significant decrease in Covid-19 deaths in ads on homoeopathy group as compared to standard of care. In adjuvant homoeopathy arm in 04 trials, total 543 patients treated with adjuvant homoeopathy, 536 patients recovered & discharged, said the Ayush minister.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|